Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XTLB Xtl生物制药

已收盘 11-26 16:00:00 EST

1.85

-0.03

-1.60%

盘后1.72

-0.13-7.03%

16:00 EST

最高1.90	最低1.70	成交量7,400
今开1.85	昨收1.88	日振幅10.64%
总市值1,008万	流通市值764.53万	总股本544.91万
成交额1.33万	换手率0.18%	流通股本413.26万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"XTLB","market":"US","secType":"STK","nameCN":"Xtl生物制药","latestPrice":1.85,"timestamp":1732654800000,"preClose":1.88,"halted":0,"volume":7400,"hourTrading":{"tag":"盘后","latestPrice":1.72,"preClose":1.85,"latestTime":"16:00 EST","volume":1,"amount":1.72,"timestamp":1732654801017},"delay":0,"floatShares":4132600,"shares":5449061,"eps":-0.0693,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.03,"latestTime":"11-26 16:00:00 EST","open":1.85,"high":1.9,"low":1.7,"amount":13321.16994,"amplitude":0.106383,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0693,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732698000000},"adr":0,"adjPreClose":1.88,"adrRate":100,"postHourTrading":{"tag":"盘后","latestPrice":1.72,"preClose":1.85,"latestTime":"16:00 EST","volume":1,"amount":1.72,"timestamp":1732654801017},"volumeRatio":1.483799},"requestUrl":"/m/hq/s/XTLB","defaultTab":"news","newsList":[{"id":"2486169883","title":"Xtl生物制药盘中异动 快速跳水7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486169883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486169883?lang=zh_cn&edition=full","pubTime":"2024-11-27 00:24","pubTimestamp":1732638265,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日00时24分，Xtl生物制药股票出现波动，股价大幅下跌7.98%。截至发稿，该股报1.73美元/股，成交量285股，换手率0.01%，振幅2.13%。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.36%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127002425971a8aee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127002425971a8aee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2486403587","title":"Xtl生物制药盘中异动 股价大跌7.98%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486403587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486403587?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:57","pubTimestamp":1732546646,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时57分，Xtl生物制药股票出现异动，股价快速跳水7.98%。截至发稿，该股报1.73美元/股，成交量14股，换手率0.00%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为1.53%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125225727971a864a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125225727971a864a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2485926218","title":"Xtl生物制药盘中异动 大幅下挫6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485926218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485926218?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:56","pubTimestamp":1732287381,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时56分，Xtl生物制药股票出现异动，股价急速下挫6.56%。截至发稿，该股报1.71美元/股，成交量195股，换手率0.00%，振幅0.00%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.45%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222562198e442cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222562198e442cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2484925746","title":"Xtl生物制药盘中异动 早盘大幅拉升5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484925746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484925746?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:09","pubTimestamp":1732028996,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时09分，Xtl生物制药股票出现异动，股价大幅上涨5.71%。截至发稿，该股报1.85美元/股，成交量474股，换手率0.01%，振幅7.45%。Xtl生物制药股票所在的生物技术行业中，整体跌幅为1.29%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119230956a2460243&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119230956a2460243&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2484677093","title":"Xtl生物制药盘中异动 早盘急速下跌5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484677093","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484677093?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:55","pubTimestamp":1731945354,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时55分，Xtl生物制药股票出现异动，股价急速下跌5.68%。截至发稿，该股报1.75美元/股，成交量1158股，换手率0.02%，振幅1.73%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.04%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823555498e434c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823555498e434c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2482084495","title":"Xtl生物制药盘中异动 大幅拉升5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482084495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482084495?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:12","pubTimestamp":1731424330,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日23时12分，Xtl生物制药股票出现波动，股价大幅拉升5.41%。截至发稿，该股报1.85美元/股，成交量632股，换手率0.01%，振幅2.28%。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.19%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112231210a230d247&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112231210a230d247&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2482756700","title":"Xtl生物制药盘中异动 下午盘快速下跌7.60%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482756700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482756700?lang=zh_cn&edition=full","pubTime":"2024-11-12 02:19","pubTimestamp":1731349180,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日02时19分，Xtl生物制药股票出现异动，股价急速下挫7.60%。截至发稿，该股报1.70美元/股，成交量2108股，换手率0.04%，振幅4.35%。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.68%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112021941abb6cc09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112021941abb6cc09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2482128438","title":"Xtl生物制药盘中异动 快速下跌6.99%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482128438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482128438?lang=zh_cn&edition=full","pubTime":"2024-11-09 01:30","pubTimestamp":1731087003,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日01时30分，Xtl生物制药股票出现异动，股价大幅跳水6.99%。截至发稿，该股报1.73美元/股，成交量1531股，换手率0.03%，振幅6.99%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.90%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110901300398e418a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110901300398e418a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2481184492","title":"Xtl生物制药盘中异动 大幅上涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481184492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481184492?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:10","pubTimestamp":1730992227,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时10分，Xtl生物制药股票出现异动，股价大幅拉升5.52%。截至发稿，该股报1.91美元/股，成交量531股，换手率0.01%，振幅4.34%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.10%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723102798e4139e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110723102798e4139e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2481363500","title":"Xtl生物制药盘中异动 大幅下跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481363500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481363500?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:31","pubTimestamp":1730817084,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时31分，Xtl生物制药股票出现波动，股价大幅下跌5.85%。截至发稿，该股报1.77美元/股，成交量605股，换手率0.01%，振幅0.00%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.34%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522312498e408bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522312498e408bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2480276581","title":"Xtl生物制药盘中异动 早盘股价大跌13.19%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480276581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480276581?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:30","pubTimestamp":1730730647,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时30分，Xtl生物制药股票出现异动，股价大幅下挫13.19%。截至发稿，该股报2.04美元/股，成交量2.1797万股，换手率0.40%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.00%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422304798e40453&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422304798e40453&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2480053495","title":"Xtl生物制药盘中异动 快速拉升7.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480053495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480053495?lang=zh_cn&edition=full","pubTime":"2024-11-01 00:24","pubTimestamp":1730391872,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日00时24分，Xtl生物制药股票出现波动，股价快速拉升7.87%。截至发稿，该股报1.92美元/股，成交量8.4466万股，换手率1.55%，振幅9.27%。Xtl生物制药股票所在的生物技术行业中，整体跌幅为3.37%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101002432a202e844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101002432a202e844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2479928316","title":"Xtl生物制药盘中异动 早盘快速跳水8.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479928316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479928316?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:30","pubTimestamp":1730208628,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时30分，Xtl生物制药股票出现异动，股价急速下挫8.43%。截至发稿，该股报1.74美元/股，成交量1.8614万股，换手率0.34%，振幅0.00%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.00%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213028a1f59e81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213028a1f59e81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2478894284","title":"Xtl生物制药盘中异动 大幅拉升5.16%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478894284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478894284?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:31","pubTimestamp":1730122261,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时31分，Xtl生物制药股票出现波动，股价急速上涨5.16%。截至发稿，该股报1.63美元/股，成交量144.174万股，换手率26.46%，振幅1.29%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.25%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821310298e3ecd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821310298e3ecd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2478593630","title":"Xtl生物制药盘中异动 早盘快速上涨5.44%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478593630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478593630?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:00","pubTimestamp":1729864808,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时00分，Xtl生物制药股票出现异动，股价急速上涨5.44%。截至发稿，该股报1.55美元/股，成交量247股，换手率0.00%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.67%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522000998e3e82e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522000998e3e82e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2477631482","title":"Xtl生物制药盘中异动 早盘急速拉升6.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477631482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477631482?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:46","pubTimestamp":1729777583,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时46分，Xtl生物制药股票出现异动，股价快速上涨6.88%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.63%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421462395bd4e1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421462395bd4e1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2477435074","title":"Xtl生物制药盘中异动 股价大跌7.42%报1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477435074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477435074?lang=zh_cn&edition=full","pubTime":"2024-10-23 00:36","pubTimestamp":1729615016,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日00时36分，Xtl生物制药股票出现波动，股价急速下挫7.42%。截至发稿，该股报1.81美元/股，成交量2083股，换手率0.04%，振幅2.56%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为1.33%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023003656ab6c44e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023003656ab6c44e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2477745868","title":"Xtl生物制药盘中异动 早盘股价大跌7.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477745868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477745868?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:30","pubTimestamp":1729517407,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时30分，Xtl生物制药股票出现波动，股价急速下挫7.99%。截至发稿，该股报1.92美元/股，成交量1577股，换手率0.03%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.00%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213007a1e24906&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213007a1e24906&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2476257677","title":"Xtl生物制药盘中异动 股价大跌6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476257677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476257677?lang=zh_cn&edition=full","pubTime":"2024-10-18 22:56","pubTimestamp":1729263417,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日22时56分，Xtl生物制药股票出现异动，股价快速下挫6.45%。截至发稿，该股报2.03美元/股，成交量5219股，换手率0.10%，振幅3.23%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.31%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018225657971a1252&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018225657971a1252&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2476178858","title":"Xtl生物制药盘中异动 大幅上涨7.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476178858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476178858?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:31","pubTimestamp":1729171882,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时31分，Xtl生物制药股票出现异动，股价大幅上涨7.07%。截至发稿，该股报2.12美元/股，成交量188股，换手率0.00%，振幅0.00%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.17%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721312295afa7af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721312295afa7af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xtlbio.com","stockEarnings":[{"period":"1week","weight":0.0743},{"period":"1month","weight":0.2129},{"period":"3month","weight":-0.2906},{"period":"6month","weight":-0.2838},{"period":"1year","weight":0.8614},{"period":"ytd","weight":0.8612}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xtl Biopharmaceuticals Ltd.在以色列国法律下于1993年3月9日依法成立。公司从事于药物产品的收购和研发，为了满足未得到满足的医疗需求。最近在致力于MM的治疗，精神分裂症和丙型肝炎。公司研究、研发和出售通过处理器治疗的非药用和非侵入性治疗多种疾病的家庭治疗设备。治疗的疾病例如有高血压、心力衰竭、失眠和精神紧张。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.120788},{"month":2,"riseRate":0.4,"avgChangeRate":-0.024778},{"month":3,"riseRate":0.4,"avgChangeRate":0.168776},{"month":4,"riseRate":0.4,"avgChangeRate":-0.03256},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.052628},{"month":6,"riseRate":0.5,"avgChangeRate":0.003823},{"month":7,"riseRate":0.4,"avgChangeRate":0.48573},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.032037},{"month":9,"riseRate":0.2,"avgChangeRate":-0.078439},{"month":10,"riseRate":0.375,"avgChangeRate":-0.021569},{"month":11,"riseRate":0.375,"avgChangeRate":-0.052873},{"month":12,"riseRate":0.2,"avgChangeRate":-0.058576}],"exchange":"NASDAQ","name":"Xtl生物制药","nameEN":"XTL Biopharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xtl生物制药(XTLB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xtl生物制药,XTLB,Xtl生物制药股票,Xtl生物制药股票老虎,Xtl生物制药股票老虎国际,Xtl生物制药行情,Xtl生物制药股票行情,Xtl生物制药股价,Xtl生物制药股市,Xtl生物制药股票价格,Xtl生物制药股票交易,Xtl生物制药股票购买,Xtl生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xtl生物制药(XTLB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}